Page last updated: 2024-08-16

timolol and 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin

timolol has been researched along with 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuda, T; Mori, M; Tsushima, H1

Other Studies

1 other study(ies) available for timolol and 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin

ArticleYear
Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiureses by vasopressin release mediated through adrenergic and angiotensin receptors.
    Japanese journal of pharmacology, 1994, Volume: 66, Issue:2

    Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Diuresis; Dose-Response Relationship, Drug; Injections, Intra-Arterial; Injections, Intraventricular; Male; Microinjections; Paraventricular Hypothalamic Nucleus; Phenoxybenzamine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Angiotensin; Supraoptic Nucleus; Timolol; Vasoconstriction; Vasopressins

1994